In the present study, we aimed to analyse the levels of SIRT1 and CLDN1 in urine pellets from hypertensive patients with and without diabetes and/or albuminuria to unravel their potential value as non-invasive biomarkers of incipient renal damage. The gene discussed is SIRT1; the disease is diabetes mellitus.